Reports for APOTEX INC
Company Name APOTEX INC |
||
|---|---|---|
Totals |
||
Shortage reports |
3367 |
|
| Actual shortage: | 219 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 341 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2022-12-09 | 2023-03-16 | 177606 |
| APO-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2022-12-23 | 2023-03-16 | 179441 |
| APO-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2018-01-10 | 2018-04-23 | 35565 |
| APO-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2018-01-17 | 2018-03-06 | 36282 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-12-08 | 2023-12-15 | 212937 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2024-04-26 | 2024-06-28 | 226318 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-05-19 | 2023-07-27 | 192806 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-08-12 | 2023-08-18 | 201696 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-10-20 | 2023-11-10 | 207719 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2019-01-09 | 2019-02-13 | 71659 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2019-03-05 | 2019-04-05 | 77875 |
| APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2022-05-27 | 2022-09-30 | 161448 |
| APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2024-07-12 | 2024-09-06 | 232821 |
| APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2023-04-14 | 2023-07-07 | 189653 |
| APO-ELETRIPTAN | 40MG | TABLET TABLET | Resolved | 2020-09-02 | 2021-11-19 | 123558 |
| APO-ELETRIPTAN | 20MG | TABLET TABLET | Resolved | 2020-11-26 | 2022-06-03 | 128925 |
| APO-ELETRIPTAN | 20MG | TABLET | Resolved | 2017-03-10 | 2020-01-07 | 305 |
| APO-ELETRIPTAN | 40MG | TABLET | Resolved | 2017-03-10 | 2020-01-07 | 308 |
| APO-ELETRIPTAN TABLETS | 40MG | TABLET | Resolved | 2024-10-10 | 2024-11-22 | 239816 |
| APO-ELTROMBOPAG | 50MG | TABLET | Resolved | 2024-03-08 | 2024-04-05 | 221699 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2021-06-25 | 2021-06-25 | 141546 |
| APO-QUININE | 200MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60711 |
| APO-QUININE | 300MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60714 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-08 | 2018-10-05 | 60717 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-09-08 | 2019-03-29 | 60720 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64965 |
| APO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60750 |